Nuclear factor of activated T-cells, NFATC1, governs FLT3ITD-driven hematopoietic stem cell transformation and a poor prognosis in AML

被引：0
|
作者：
Maria Solovey
Ying Wang
Christian Michel
Klaus H. Metzeler
Tobias Herold
Joachim R. Göthert
Volker Ellenrieder
Elisabeth Hessmann
Stefan Gattenlöhner
Andreas Neubauer
Dinko Pavlinic
Vladimir Benes
Oliver Rupp
Andreas Burchert
机构：
[1] Philipps University Marburg,Department of Hematology, Oncology and Immunology, University Hospital Giessen and Marburg, Campus Marburg
[2] LMU Munich,Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital
[3] University Hospital Essen,Department of Hematology
[4] University Hospital Goettingen,Department of Gastroenterology
[5] Justus-Liebig-University,Institute of Pathology
[6] EMBL Heidelberg ,Genomics Core Facility
[7] University Giessen,Department of Bioinformatics and Systems Biology
来源：
Journal of Hematology & Oncology | / 12卷
关键词：
FLT3; Acute myeloid leukemia; Hematopoietic stem cells; NFATC1; Drug resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome
    Jindra, Pavel
    Raida, Ludek
    Karas, Michal
    Szotkowski, Tomas
    Lysak, Daniel
    Hrabetova, Marcela
    Jungova, Alexandra
    Steinerova, Katerina
    Faber, Edgar
    Papajik, Tomas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (07): : 462 - 469
  • [22] NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML
    Sportoletti, P.
    Varasano, E.
    Rossi, R.
    Celani, L.
    Rompietti, C.
    Strozzini, F.
    Proietti, A. Alunni
    Del Papa, B.
    Bonifacio, E.
    Bereshchenko, O.
    Martelli, M. P.
    Falzetti, F.
    Falini, B.
    HAEMATOLOGICA, 2014, 99 : 256 - 256
  • [23] THE DNMT3A R882 MUTATION WITH FLT3-ITD POSITIVITY IS AN EXTREMELY POOR PROGNOSTIC FACTOR IN PATIENTS WITH NORMAL KARYOTYPE AML AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Ahn, J. S.
    Kim, H. J.
    Kim, Y. K.
    Jung, S. H.
    Yang, D. H.
    Lee, J. J.
    Kim, N. Y.
    Choi, S. H.
    Jung, C. W.
    Jang, J. H.
    Kim, H. J.
    Moon, J. H.
    Sohn, S. K.
    Won, J. H.
    Kim, S. H.
    Kim, D. D. H.
    HAEMATOLOGICA, 2015, 100 : 385 - 386
  • [24] Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: A GOELAMS study
    Guieze, Romain
    Cornillet-Lefebvre, Pascale
    Lioure, Bruno
    Blanchet, Odile
    Pigneux, Arnaud
    Recher, Christian
    Bonmati, Caroline
    Fegueux, Nathalie
    Bulabois, Claude-Eric
    Bouscary, Didier
    Vey, Norbert
    Delain, Martine
    Turlure, Pascal
    Himberlin, Chantal
    Harousseau, Jean-Luc
    Dreyfus, Francois
    Bene, Marie C.
    Ifrah, Norbert
    Chevallier, Patrice
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (12) : 1052 - 1056
  • [25] The Comparative Value of Hematopoietic Stem Cell Transplantation and Chemotherapy in Cytogenetically Normal AML Subclassified By NPM1 Mutation Status and FLT3-ITD Allelic Ratio
    Versluis, Jurjen
    Devillier, Raynier
    In't Hout, Florentien
    van Putten, Wim
    Manz, Markus G.
    Vekemans, Marie-Christianne
    Schaafsma, Martyn Ronald
    Passweg, Jakob R.
    Maertens, Johan
    Kuball, Jurgen H.
    Verdonck, Leo F.
    Biemond, Bart J.
    Valk, Peter J. M.
    Mozziconacci, Marie-Joelle
    Vey, Norbert
    Schouten, Harry C.
    Vellenga, Edo
    Pabst, Thomas
    Lowenberg, Bob
    Ossenkoppele, Gert J.
    Blaise, Didier
    Huls, Gerwin A.
    Cornelissen, Jan J.
    BLOOD, 2014, 124 (21)
  • [26] Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML
    Garg, Swati
    Reyes-Palomares, Armando
    He, Lixiazi
    Bergeron, Anne
    Lavallee, Vincent-Philippe
    Lemieux, Sebastien
    Gendron, Patrick
    Rohde, Christian
    Xia, Jianglong
    Jagdhane, Prarabdha
    Mueller-Tidow, Carsten
    Lipka, Daniel B.
    Imren, Suzan
    Humphries, R. Keith
    Waskow, Claudia
    Vick, Binje
    Jeremias, Irmela
    Richard-Carpentier, Guillaume
    Hebert, Josee
    Sauvageau, Guy
    Zaugg, Judith B.
    Barabe, Frederic
    Pabst, Caroline
    BLOOD, 2019, 134 (03) : 263 - 276
  • [27] Metabotropic glutamate receptor (mGLUR) activation causes NFATc3 (nuclear factor of activated T-cells) nuclear accumulation in both astrocytes and pericytes in rat somatosensory cortex
    Filosa, J
    Bosc, LVG
    Nelson, MT
    FASEB JOURNAL, 2004, 18 (05): : A1009 - A1009
  • [28] Treatment of Molecular Relapse by Cessation of Immunosuppression After Hematopoietic Stem Cell Transplantation in Pediatric FLT3-ITD AML Monitored by WT1 Expression in Peripheral Blood
    Juul-Dam, Kristian Lovvik
    Ifversen, Marianne
    Nyvold, Charlotte Guldborg
    Hansen, Maria
    Hasle, Henrik
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (05) : 417 - 419
  • [29] Estrogen Controls embryonic stem cell proliferation via store-operated calcium entry and the nuclear factor of activated T-cells (NFAT)
    Wong, Chun-Kit
    So, Wing-Yan
    Law, Sau-Kwan
    Leung, Fung-Ping
    Yau, Ka-Long
    Yao, Xiaoqiang
    Huang, Yu
    Li, Xiangdong
    Tsang, Suk-Ying
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (06) : 2519 - 2530
  • [30] Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis
    Huang, Yan
    Hu, Juan
    Lu, Ting
    Luo, Yi
    Shi, Jimin
    Wu, Wenjun
    Han, Xiaoyan
    Zheng, Weiyan
    He, Jingsong
    Cai, Zhen
    Wei, Guoqing
    Huang, He
    Sun, Jie
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 4129 - 4142
12345